HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Katia Bencardino Selected Research
Katia Bencardino Research Topics
Disease
27
Colorectal Neoplasms (Colorectal Cancer)
02/2024 - 03/2010
20
Neoplasms (Cancer)
02/2024 - 12/2005
4
Disease Progression
12/2020 - 06/2012
3
Breast Neoplasms (Breast Cancer)
06/2010 - 09/2007
2
Circulating Neoplastic Cells
05/2021 - 01/2021
2
Rectal Neoplasms (Rectal Cancer)
01/2020 - 09/2019
2
Renal Cell Carcinoma (Grawitz Tumor)
01/2017 - 05/2006
2
Neoplasm Metastasis (Metastasis)
06/2012 - 05/2006
2
Febrile Neutropenia
06/2010 - 12/2005
1
Nausea
06/2023
1
Vomiting
06/2023
1
Myasthenia Gravis
02/2021
1
Thymoma (Thymic Carcinoma)
02/2021
1
Respiratory Insufficiency (Respiratory Failure)
02/2021
1
Mammary Analogue Secretory Carcinoma
01/2017
1
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2017
1
Central Nervous System Diseases (CNS Diseases)
01/2017
1
Melanoma (Melanoma, Malignant)
01/2017
1
Exanthema (Rash)
06/2016
1
Fatigue
06/2016
1
Gastrointestinal Neoplasms (Gastrointestinal Cancer)
05/2014
1
Carcinogenesis
03/2014
1
Anemia
06/2010
1
Leukocytosis (Pleocytosis)
06/2010
1
Carcinoma (Carcinomatosis)
05/2006
1
Neutropenia
12/2005
Drug/Important Bio-Agent (IBA)
7
Cetuximab (Erbitux)
FDA Link
01/2021 - 03/2010
5
Monoclonal Antibodies
IBA
01/2023 - 03/2010
5
Panitumumab (Vectibix)
FDA Link
01/2022 - 03/2010
5
Biomarkers (Surrogate Marker)
IBA
01/2021 - 03/2014
4
Circulating Tumor DNA
IBA
11/2023 - 09/2019
4
Oxaliplatin (Eloxatin)
FDA Link
Generic
06/2023 - 01/2016
4
Trastuzumab (Herceptin)
FDA Link
12/2020 - 11/2015
4
Lapatinib (GW572016)
FDA Link
12/2020 - 11/2015
3
regorafenib
IBA
01/2019 - 03/2014
3
ErbB Receptors (EGF Receptor)
IBA
02/2014 - 03/2010
2
Proteins (Proteins, Gene)
FDA Link
02/2024 - 11/2015
2
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
01/2021 - 06/2011
2
Cell-Free Nucleic Acids
IBA
01/2021 - 11/2018
2
pertuzumab
IBA
12/2020 - 01/2020
2
DNA (Deoxyribonucleic Acid)
IBA
01/2019 - 06/2011
2
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
02/2014 - 06/2012
2
Filgrastim (Neupogen)
FDA Link
06/2010 - 01/2009
2
pegfilgrastim (Neulasta)
FDA Link
06/2010 - 09/2007
1
Protein-Arginine N-Methyltransferases (Methyltransferase, Protein Arginine)
IBA
02/2024
1
chenodeoxycholate sulfate conjugate (CDCS)
IBA
12/2023
1
Cisplatin (Platino)
FDA Link
Generic
02/2021
1
Pyridostigmine Bromide (Pyridostigmine)
FDA Link
Generic
02/2021
1
Cyclophosphamide (Cytoxan)
FDA Link
Generic
02/2021
1
Intravenous Immunoglobulins (IVIG)
FDA Link
02/2021
1
Doxorubicin (Adriamycin)
FDA Link
Generic
02/2021
1
Steroids
IBA
02/2021
1
encorafenib
IBA
01/2021
1
Immune Checkpoint Inhibitors
IBA
01/2021
1
mesoglycan
IBA
01/2020
1
Ado-Trastuzumab Emtansine
IBA
01/2020
1
entrectinib
IBA
01/2017
1
Phosphotransferases (Kinase)
IBA
01/2017
1
Tyrosine (L-Tyrosine)
FDA Link
01/2017
1
Aligeron (AS 2)
IBA
01/2017
1
Bilirubin
IBA
06/2016
1
Codon (Codons)
IBA
06/2016
1
Protein Kinases (Protein Kinase)
IBA
03/2014
1
Growth Factor Receptors
IBA
03/2014
1
Angiopoietin-1
IBA
03/2014
1
Calcibiotic Root Canal Sealer
IBA
02/2014
1
Antibodies
IBA
02/2014
1
Aspirin (Acetylsalicylic Acid)
FDA Link
Generic
07/2013
1
Dacarbazine (DIC)
FDA Link
Generic
04/2013
1
DNA Repair Enzymes
IBA
04/2013
1
Lenalidomide (CC 5013)
FDA Link
01/2013
1
Bevacizumab (Avastin)
FDA Link
06/2011
1
taxane
IBA
06/2010
1
Colony-Stimulating Factors (Colony Stimulating Factor)
IBA
06/2010
1
Hemoglobins (Hemoglobin)
IBA
06/2010
1
Anthracyclines
IBA
06/2010
1
Epirubicin (Ellence)
FDA Link
Generic
09/2007
1
Docetaxel (Taxotere)
FDA Link
09/2007
1
Interferon-alpha (Interferon Alfa)
IBA
05/2006
1
Interleukin-2 (IL2)
IBA
05/2006
1
Granulocyte Colony-Stimulating Factor (G-CSF)
IBA
12/2005
Therapy/Procedure
9
Therapeutics
01/2017 - 03/2010
5
Drug Therapy (Chemotherapy)
02/2021 - 09/2007
4
Retreatment
11/2023 - 02/2019
2
Immunotherapy
02/2019 - 05/2006
1
Artificial Respiration (Mechanical Ventilation)
02/2021
1
Radiotherapy
02/2021
1
Contraindications
02/2021
1
Plasma Exchange
02/2021
1
Critical Care (Surgical Intensive Care)
02/2021
1
Precision Medicine
01/2021
1
Neoadjuvant Therapy
06/2010
1
Adjuvant Chemotherapy
01/2009
1
Nephrectomy
05/2006